Equity Overview
Price & Market Data
Price: $2.99
Daily Change: $0.00 / 0.00%
Daily Range: $2.55 - $4.45
Market Cap: $167,151,504
Daily Volume: 1,519,532
Performance Metrics
1 Week: -18.97%
1 Month: 15.44%
3 Months: 6.03%
6 Months: 99.33%
1 Year: 374.2%
YTD: 6.03%
Company Details
Employees: 62
Sector: Health technology
Industry: Pharmaceuticals: major
Country: United States
Details
Connect Biopharma Holdings Limited, a clinical-stage biopharmaceutical company, engages in the development of therapies for the treatment of inflammatory diseases in the United States. The company's lead product candidate is rademikibart (formerly CBP-201), an antibody designed to target interleukin-4 receptor alpha, which is in Phase 3 studies for the treatment of inflammatory diseases such as atopic dermatitis and asthma. Connect Biopharma Holdings Limited was founded in 2012 and is headquartered in San Diego, California.